PMX-30063: Phase I data

A double-blind, U.S. Phase I trial in 20 healthy volunteers showed that high-dose IV PMX-30063 was

Read the full 162 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE